Author: Cannegieter, Suzanne C; Klok, Frederikus A
Title: COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Cord-id: set5uw47 Document date: 2020_1_1
ID: set5uw47
Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the causative pathogen of a new infectious disease, COVID-19, that first occurred in late December 2019 in the city of Wuhan in Hubei Province, China. It has since spread globally, resulting in a WHO declared pandemic, with as yet (17/4/20) more than two million confirmed cases and about 150.000 confirmed deaths. As for every new disease, clinicians, hospitals and governments struggle to find optimal clinical and public health me
Document: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the causative pathogen of a new infectious disease, COVID-19, that first occurred in late December 2019 in the city of Wuhan in Hubei Province, China. It has since spread globally, resulting in a WHO declared pandemic, with as yet (17/4/20) more than two million confirmed cases and about 150.000 confirmed deaths. As for every new disease, clinicians, hospitals and governments struggle to find optimal clinical and public health measures to contain its spread and burden. For this, information from scientific research is crucial and fortunately we see a rapidly accumulating output of studies.
Search related documents:
Co phrase search for related documents- academic medical center and acute coronary syndrome: 1, 2, 3
- acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acs acute coronary syndrome incidence and acute coronary syndrome: 1
- acs consistent and acute coronary syndrome: 1, 2
- acs present and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- acute coronary syndrome and lmwh low molecular weight heparin: 1
Co phrase search for related documents, hyperlinks ordered by date